Synthon
Synthon is a pharmaceutical company and a leader in the field of generic medicines.
Based in Nijmegen, the Netherlands, the company started its biopharmaceutical franchise in 2007 and is building a promising portfolio of next generation medicines.
Synthon is focusing increasingly on the therapeutic areas of oncology and auto-immune diseases.
In 2015 the company recorded its turnover at $301 million.
Latest Synthon News & Features
13 September 2017
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze